PO-03-216 HYBRID VT ABLATION-SUBCUTANEOUS ICD MANAGEMENT STRATEGY FOR SECONDARY PREVENTION OF SUDDEN CARDIAC DEATH: THE VTABL-SICD TRIAL
نویسندگان
چکیده
We hypothesized that a novel hybrid management strategy combines VT ablation (VTabl) for the prevention of slow recurrence, with subcutaneous ICD (S-ICD) placement termination faster life-threatening VT/VF, will reduce need lower-rate therapies by transvenous (TV-ICD) programmed to terminate any (including clinical VT).
منابع مشابه
Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
Implantation of a transvenous implantable cardioverter-defibrillator (ICD) is a recognized method of secondary prevention of sudden cardiac death [1]. In some patients with indications for such a device, circumstances may occur that render ICD implantation difficult or impossible. Implantation of a subcutaneous ICD (S-ICD), not requiring introduction of any elements into the cardiovascular syst...
متن کامل[Primary and secondary prevention of sudden cardiac death].
Implantable cardioverter defibrillators (ICDs) are the mainstay of modern device-based therapy for ventricular arrhythmias. Originally developed for patients resuscitated from cardiac arrest, the vast majority of today’s ICDs are implanted prophylactically in patients with heart failure at increased risk for ventricular arrhythmias. The objective of this review is to provide a concise overview ...
متن کاملPrevention of Sudden Cardiac Death
Sudden cardiac death (SCD) due ventricular tachyarrhythmias is an important cause of mortality world wide. While the majority of these deaths occur in those with structural heart disease, a small percentage (about 4%) can occur in those with structurally normal heart as well [1]. Such primary electrical disorders of the heart which cause SCD are now called as channelopathies as they involve the...
متن کاملPrevention of sudden cardiac death.
Although the annual incidence of sudden cardiac death (SCD) is dropping in the United States, therapies for the patient who has survived a SCD episode or is at high risk of developing SCD in the future are now well established. The implantable cardioverter defibrillator (ICD) has emerged from a series of well done randomized clinical trials of the 1990s as providing a survival benefit in carefu...
متن کاملClinical management and prevention of sudden cardiac death.
Despite the revolutionary advancements in the past 3 decades in the treatment of ventricular tachyarrhythmias with device-based therapy, sudden cardiac death (SCD) remains an enormous public health burden. Survivors of SCD are generally at high risk for recurrent events. The clinical management of such patients requires a multidisciplinary approach from postresuscitative care to a thorough card...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart Rhythm
سال: 2023
ISSN: ['1556-3871', '1547-5271']
DOI: https://doi.org/10.1016/j.hrthm.2023.07.016